Total Funding
39
64
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
137421
Mutabilis is discovery of new therapeutic targets for the development of anti-infectives.
- Stephane Huguet: Founder & CEO
About the Company
Mutabilis is discovery of new therapeutic targets for the development of anti-infectives.
Mutabilis is a biopharmaceutical company specialised in the discovery and development of anti-infectives. Mutabilis discovers and develops innovative anti-infectives, a novel class of drug addressing the current issues arising from resistance to antibiotics
and targeting severe bacterial infections. Mutabilis’ new therapies target nosocomial infections in particular.
